Drug Metabolism and Pharmacokinetics (DMPK)
Integrated Discovery and Standalone Services: Evaluate preclinical ADME, PK/TK and PK/PD properties with on-demand in vitro and in vivo studies and turnaround times as fast as 5 days.
DMPK Services Overview
in vivo PK/TK studies and assays
in vitro ADME studies and assays
Bioanalytical service
300+ clients per year
250+ IND programs supported
DMPK Services: End-to-End Preclinical Capabilities
BioDuro-Sundia provides DMPK services through its unique position as a global CRDMO supporting new drug discovery, development, and commercial manufacturing. With seamless internal collaboration with medicinal chemistry, discovery biology, pharmacology, and formulation development teams, our DMPK services cover various in vitro and in vivo assays to evaluate the ADME and PK properties of drug candidates during lead finding and optimization, subsequently PCC nomination and IND-enabling for a wide range of modalities including small molecule, peptide, protein, ADA and biomarker.
Flexible DMPK Contract Services
Fee-for-service (FFS) or full-time-equivalent (FTE)
Integrated drug discovery package
IND enabling package
Fast Results: DMPK Assays and Bioanalysis
Results as fast as 5 days turnaround time
Start immediately - No wait time
Complete DMPK Capabilities
AAALAC accredited vivarium at two facilities (1,600 m2)
Early phase screening to later bioanalytical service
Toxicity studies in rodent, dog and monkeys models
Small and large molecule DMPK service capabilities
Home
